Shu‐Jen Chen

National Health Research Institutes — Taiwan

Biochemistry, Genetics and Molecular Biology · Life Sciences

43h-index8.0kcitations240works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(32), MicroRNA in disease regulation(25), Genetic factors in colorectal cancer(20), Virus-based gene therapy research(19), Cancer-related molecular mechanisms research(18)

Publications240 total

Study of sex-biased differences in genomic profiles in East Asian hepatocellular carcinoma
Discover Oncology·2024· 5 citedOpen Access
Comprehensive genomic profiling and therapeutic implications for Taiwanese patients with treatment‐naïve breast cancer
Cancer Medicine·2024· 2 citedOpen Access
Analysis of mutation profiles in extranodal NK/T-cell lymphoma: clinical and prognostic correlations
Annals of Hematology·2024· 5 cited
Significant Differences in Capsid Properties and Potency Between Adeno-Associated Virus Vectors Produced in Sf9 and HEK293 Cells
Human Gene Therapy·2023· 16 cited
Exploring the Anti-Cancer Effects of Fish Bone Fermented Using Monascus purpureus: Induction of Apoptosis and Autophagy in Human Colorectal Cancer Cells
Molecules·2023· 4 citedOpen Access
Data from Targeted Sequencing of Circulating Tumor DNA to Monitor Genetic Variants and Therapeutic Response in Metastatic Colorectal Cancer
2023Open Access
Table S2 from Targeted Sequencing of Circulating Tumor DNA to Monitor Genetic Variants and Therapeutic Response in Metastatic Colorectal Cancer
2023Open Access
Table S1 from Targeted Sequencing of Circulating Tumor DNA to Monitor Genetic Variants and Therapeutic Response in Metastatic Colorectal Cancer
2023Open Access
Table S1 from Targeted Sequencing of Circulating Tumor DNA to Monitor Genetic Variants and Therapeutic Response in Metastatic Colorectal Cancer
2023Open Access
Data from Targeted Sequencing of Circulating Tumor DNA to Monitor Genetic Variants and Therapeutic Response in Metastatic Colorectal Cancer
2023Open Access
Table S2 from Targeted Sequencing of Circulating Tumor DNA to Monitor Genetic Variants and Therapeutic Response in Metastatic Colorectal Cancer
2023Open Access
Table S3 from Targeted Sequencing of Circulating Tumor DNA to Monitor Genetic Variants and Therapeutic Response in Metastatic Colorectal Cancer
2023Open Access
Table S3 from Targeted Sequencing of Circulating Tumor DNA to Monitor Genetic Variants and Therapeutic Response in Metastatic Colorectal Cancer
2023Open Access
Supplementary Figure from Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study
2023Open Access
Supplementary Figure from Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study
2023Open Access
Supplementary Figure from Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study
2023Open Access
Supplementary Figure from Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study
2023Open Access
Supplementary Figure from Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study
2023Open Access
Supplementary Figure from Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study
2023Open Access
Data from Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study
2023Open Access
page 1 of 12Next →

Frequent Co-authors

James M. Wilson(12), Hua‐Chien Chen(11), Yu‐Sun Chang(6), Hung‐Chih Hsu(5), Jenny A. Greig(5), Peter Bell(5), An Hsu(4), Kai‐Ping Chang(3), Wen‐Sy Tsai(3), Tsai‐Sheng Yang(3), Teh‐Liang Chen(3), Nina Lapke(3), Maria P. Limberis(3), Roberto Calcedo(3), Daniel J. Rader(3), Guangping Gao(2), Krishna J. Fisher(2), Yasuji Mori(2), John Varga(2), Martin Lock(2)